Long-term effects of mitomycin-C on residual aberration and optical quality after photorefractive keratectomy in eyes with low to moderate myopia

The introduction of mitomycin-C (MMC) has improved the outcomes of photorefractive keratectomy (PRK) by preventing haze formation and reducing light scatter.1 Mitomycin-C is routinely used when the ablation depth goes beyond certain limits (eg, ablations deeper than 60  mm) and in hyperopic and highly toric ablations.2 Some surgeons use MMC for every excimer laser ablation regardless of the intended correction.
Source: Journal of Cataract and Refractive Surgery - Category: Opthalmology Authors: Tags: Correspondence Source Type: research